Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance — Laurence Zitvogel (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Shared by
Guido Guido Kroemer
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Article
2013
en
Authors
+1 more
LZ
Laurence Zitvogel
LG
Lorenzo Galluzzi
MS
Mark J. Smyth
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Letter
2014
Targeting Foxp1 for Reinstating Anticancer Immunosurveillance
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2015
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi
,
Aitziber Buqué
,
Oliver Kepp
,
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2016
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel
,
Maha Ayyoub
,
Bertrand Routy
,
Guido Guido Kroemer
Letter
2015
Subversion of anticancer immunosurveillance by radiotherapy
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2019
Contribution of annexin A1 to anticancer immunosurveillance
Elisa Elena Baracco
,
Gautier Stoll
,
Peter Van Endert
,
Laurence Zitvogel
,
Erika Vacchelli
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.